For research use only. Not for therapeutic Use.
<p style=/line-height:25px/>1-Naphthyl PP1(1-NA-PP 1) is a selective inhibitor of src family kinases v-Src and c-Fyn as well as the tyrosine kinase c-Abl (IC50 values are 1.0, 0.6, 0.6, 18 and 22 μM for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II respectively).<br>IC50 Value:1.0 uM (v-Src); 0.6 uM (c-Fyn); 18 uM (c-Abl) [1]<br>Target: Src Family kinase<br>1-NA-PP1 was considerably more potent and showed distinct substituent effects at the pyrazolopyrimidine core. 1-NA-PP1 was cell-active, and potently blocked prostate cancer cell proliferation by inducing G2/M arrest. Overexpression of PKD1 or PKD3 almost completely reversed the growth arrest and the inhibition of tumor cell invasion caused by 1-NA-PP1, indicating that its anti-proliferative and anti-invasive activities were mediated through the inhibition of PKD. Interestingly, a 12-fold increase in sensitivity to 1-NA-PP1 could be achieved by engineering a gatekeeper mutation in the active site of PKD1, suggesting that 1-NA-PP1 could be paired with the analog-sensitive PKD1(M659G) for dissecting PKD-specific functions and signaling pathways in various biological systems [2].<br></p>
Catalog Number | I002694 |
CAS Number | 221243-82-9 |
Synonyms | 1-tert-butyl-3-naphthalen-1-ylpyrazolo[3,4-d]pyrimidin-4-amine |
Molecular Formula | C19H19N5 |
Purity | ≥95% |
Target | Apoptosis |
Solubility | DMSO: ≤ 14.25 mg/mL |
Storage | Store at +4C |
IC50 | 1.0 uM (v-Src); 0.6 uM (c-Fyn); 18 uM (c-Abl) [1] |
InChIKey | XSHQBIXMLULFEV-UHFFFAOYSA-N |
Reference | <p style=/line-height:25px/> |